Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis

Treatment of drug-resistant tuberculosis is hindered by the high toxicity and poor efficacy of second-line drugs. New compounds must be used together with existing drugs, yet clinical trials to optimize combinations of drugs for drug-resistant tuberculosis are lacking. We conducted an extensive revi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dooley, Kelly E., Mitnick, Carole D., Ann DeGroote, Mary, Obuku, Ekwaro, Belitsky, Vera, Hamilton, Carol D., Makhene, Mamodikoe, Shah, Sarita, Brust, James C. M., Durakovic, Nadza, Nuermberger, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Antimicrobial Resistance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520382/
https://ncbi.nlm.nih.gov/pubmed/22615332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados